IJCRR - Vol 08 Issue 06, March, 2016
THE BETHESDA SYSTEM FOR REPORTING THYROID CYTOPATHOLOGY: A TWO YEAR INSTITUTIONAL AUDIT
Author: Salma Bhat, Nazia Bhat, Humaira Bashir, Summiya Farooq, Ruby Reshi, Mir Junaid Nazeir, Isma Niyaz
Fine needle aspiration cytology (FNAC) of thyroid plays a significant crucial role in cytopathology worldwide. Thyroid FNAC is extremely useful in identifying a substantial proportion of thyroid nodules as benign and reducing unnecessary surgery for patients with benign disease. The present study was done with the aim of stratifying thyroid cytology smears by The Bethesda System For Reporting Thyroid Cytopathology (TBSRTC) into various diagnostic categories, analyze their cytological features using TBSRTC monograph, convey brief management plan to the clinicians, and correlate with histology of surgical specimens received Methods: This was a prospective study done on 600 cases of fine needle aspirations of thyroid nodules over a period of two years from July 2013 to June 2015. Results: Mean age of the patients included in the study was 36 years(11–73) and male to female ratio was 2:6. Out of total 600 cases, 40 cases were non diagnostic (Bethesda Category I), 492 cases were diagnosed as benign (Bethesda category II) and 12 were Bethesda category III while 41 cases were categorized as either malignant or suspicious for malignancy (Bethesda category V and VI). Histopathologic correlation was available in 113 cases. Conclusion: TBSRTC is an excellent reporting system for thyroid cytopathology. It also provides clear management guidelines to clinicians to go for follow up FNA or surgery and also the extent of surgery.
Keywords: Thyroid nodule, Cytology, The Bethesda system, Histopathology
Salma Bhat, Nazia Bhat, Humaira Bashir, Summiya Farooq, Ruby Reshi, Mir Junaid Nazeir, Isma Niyaz. THE BETHESDA SYSTEM FOR REPORTING THYROID CYTOPATHOLOGY: A TWO YEAR INSTITUTIONAL AUDIT International Journal of Current Research and Review. Vol 08 Issue 06, March, 05-11
1. Cibas E S, Ali SZ. The Bethesda System for Reporting Thyroid Cytopathology.Am J Clin Pathol. 2009;132(5):658-665.
2. Baloch Z W, LiVolsi V A, Asa S L et al. Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the national cancer institute thyroid fineneedle aspiration state of the science conference. Diagnostic Cytopathology. 2008;36(6):425-437.
3. Mehra P and A. K. Verma A K. Thyroid cytopathology reporting by the bethesda system: a two-year prospective study in an academic institution. Pathology Research International.2015; Article ID 240505, 11 pages.
4. S. Z. Ali and E. S. Cibas, Eds. The Bethesda System for Reporting Thyroid Cytopathology. Definitions, Criteria and Explanatory Notes, Springer, New York, NY, USA, 2010.
5. Jo VY, Stelow EB, Dustin SM, Hanley KZ. Malignancy risk for fine-needle aspiration of thyroid lesions according to the Bethesda System for Reporting Thyroid Cytopathology. Am J Clin Pathol.2010;134(3):450-6.
6. Crothers BA, Henry MR, Firat P, Hamper UM. Chapter 2; Non Diagnostic/Unsatisfactory. In: Ali SZ, Cibas ES, editors. The Bethesda System for Reporting Thyroid Cytopathology. New York, NY: Springer; 2010. pp. 5-7.
7. Haider AS, Rakha EA, Dunkley C, Zaitoun AM. The impact of using defined criteria for adequacy of fine needle aspiration cytology of the thyroid in routine practice. Diagn Cytopathol. 2011;39(2):81-6.
8. Schinstine M. A brief description of the Bethesda system for reporting thyroid fine needle aspirates.Hawaii Med J. 2010;69:176-8.
9. Renshaw AA . Significance of repeatedly nondiagnostic thyroid fine-needle aspirations. Am J Clin Pathol.2011;135 (5):750-2.
10. Cooper DS, Doherty GM, Haugen B R et al. Revised American thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19(11):1167-1214.
11. Ohori NP, Schoedel KE. Variability in the atypia of undetermined significance/follicular lesion of undetermined significance diagnosis in the Bethesda System for Reporting Thyroid Cytopathology: sources and recommendations. Acta Cytologica. 2011;55(6):492-498.
12. Yassa L, Cibas ES, Benson CB, et al. Long-term assessment of a multidisciplinary approach to thyroid nodule diagnostic evaluation. Cancer. 2007;111:508-516.
13. Yang J, Schnadig V, Logrono R, et al. Fine needle aspiration of thyroid nodules: a study of 4703 patients with histological and clinical correlations. Cancer. 2007;111:306-315.
14. Logani S, Gupta PK, LiVolsi VA, et al. Thyroid nodule with FNA cytology suspicious for follicular variant of papillary thyroid carcinoma: follow-up and management. Diagn Cytopathol. 2000;23:380-385.
15. Hassell, L. A., Gillies, E. M. and Dunn, S. T., Cytologic and molecular diagnosis of thyroid cancers. Cancer Cytopathology,2012; 120: 7-17.
16. Renuka IV, Saila Bala G, Aparna C, Kumari R, Sumalatha K. The Bethesda System for Reporting Thyroid Cytopathology: Interpretation and Guidelines in Surgical Treatment. Indian Journal of Otolaryngology and Head and Neck Surgery. 2012;64(4):305- 311.